MedTrace Logo

Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors

NCT07755176 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-08-10

No results posted yet for this study

Summary

This study will evaluate patient-reported outcomes before and after percutaneous ablation of desmoid tumors. Adult participants undergoing ablation for desmoid tumor will complete surveys pre and post procedure to assess symptom burden, impact on daily life, early post-procedural pain and recovery, concomitant treatments, and radiological response following ablation.

Conditions

  • Desmoid Tumor
  • Aggressive Fibromatoses

Interventions

PROCEDURE

Desmoid tumor ablation

Percutaneous ablation of desmoid tumor

Sponsors & Collaborators

Principal Investigators

  • Rebecca Hibbert, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07755176 on ClinicalTrials.gov